Results 321 to 330 of about 12,483,860 (378)
Some of the next articles are maybe not open access.
TUMOR-ASSOCIATED ANTIGENS IN GYNECOLOGIC CANCER
Clinical Obstetrics and Gynecology, 1975If the study of tumor immunology is to have a profound impact on clinical medicine, certain hypotheses must be proven to be valid. First and foremost, it must be demonstrated that malignant tissue possesses antigenic substances (probably protein moieties) that are unique to that particular malignant process.
openaire +2 more sources
2005
The results of an extensive series of studies that were first carried out in the early 1990s have revealed that human tumor reactive T cells recognize a diverse array of antigens. These include antigens expressed in normal tissues, mutated gene products as well as novel epitopes encoded within alternative open reading frames, intronic sequences, as ...
openaire +1 more source
The results of an extensive series of studies that were first carried out in the early 1990s have revealed that human tumor reactive T cells recognize a diverse array of antigens. These include antigens expressed in normal tissues, mutated gene products as well as novel epitopes encoded within alternative open reading frames, intronic sequences, as ...
openaire +1 more source
Analysis of Murine Oncofetal Antigens as Tumor-Associated Transplantation Antigens
The Journal of Immunology, 1976Abstract In previous studies with in vitro activated cytotoxic T lymphocytes, we have demonstrated the presence of oncofetal antigens (OFA) on a range of murine tumor cells. The present studies with the same tumor lines attempt to determine whether these antigens are also capable of activating lymphocyte responses in vivo.
Chism, S E +3 more
openaire +2 more sources
Interactions of tumor-associated fetal antigens with rat histocompatibility antigens
Cellular Immunology, 1981Abstract The physical interactions of fetal antigens (tumor-associated fetal antigens; TAFA-I, TAFA-II, and TAFA-III) with rat histocompatibility antigens were studied. TAFA-I and TAFA-III are present on syngeneic (NBR) and allogeneic (Fisher F344, Wistar Furth, and White Buffalo) rat embryo fibroblasts and on tumor cells.
M C, Cerrone, D L, Evans
openaire +2 more sources
A Study of Tumor-Associated Antigens
1987The development of the hybridoma technique [8] has provided a powerful new tool for studies of tumor-associated antigens. Since 1978 Koprowski [9] and other investigators have prepared monoclonal antibodies (McAbs) to human melanoma, leukemia, lymphoma, colon cancer, breast cancer, lung cancer, and others.
Dong Zhi-Wei +4 more
openaire +1 more source
Tumor‐associated carbohydrate antigens
Journal of Oral Pathology & Medicine, 1987E, Dabelsteen, H, Clausen
openaire +2 more sources
Clinical Utility of Solid Tumor Epigenetics
Medical Epigenetics, 2021Sevin Turcan, Julian Taranda
exaly
Critical Care Management of Chimeric Antigen Receptor T-Cell Therapy Recipients
Ca-A Cancer Journal for Clinicians, 2022Sandrine Valadè +2 more
exaly
Brain and Other Central Nervous System Tumor Statistics, 2021
Ca-A Cancer Journal for Clinicians, 2021Rebecca L. Siegel +2 more
exaly

